Evidence map›Paper›PMID 36255240›Full record

ArticlemBio2022

Caspase-Mediated Regulation and Cellular Heterogeneity of the cGAS/STING Pathway in Kaposi's Sarcoma-Associated Herpesvirus Infection.

Tate Tabtieng, Rachel C Lent, Machika Kaku, Alvaro Monago Sanchez, Marta Maria Gaglia

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Tate Tabtieng *Department of Molecular Biology and Microbiology, Tufts Universitygrid.429997.8 School of Medicine, Boston, Massachusetts, USA.
Rachel C Lent *Department of Molecular Biology and Microbiology, Tufts Universitygrid.429997.8 School of Medicine, Boston, Massachusetts, USA.
Machika KakuDepartment of Molecular Biology and Microbiology, Tufts Universitygrid.429997.8 School of Medicine, Boston, Massachusetts, USA.
Alvaro Monago SanchezDepartment of Molecular Biology and Microbiology, Tufts Universitygrid.429997.8 School of Medicine, Boston, Massachusetts, USA.
Marta Maria GagliaDepartment of Molecular Biology and Microbiology, Tufts Universitygrid.429997.8 School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-1791-0663
Tufts University · US

Funding

MOLECULAR GENETICS OF BASIC CELL FUNCTIONST32GM007310 · NIGMS · TUFTS UNIVERSITY BOSTON · PI CAMILLI, ANDREW · 1987 to 2020
$3.9M
Determining how Kaposi’s sarcoma-associated herpesvirus hijacks caspase function to inhibit anti-viral responsesR01CA268976 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Marta Maria Gaglia · 2022 to 2026
$1.8M
NCI NIH HHS R01 CA268976NIGMS NIH HHS T32 GM007310
6 · The paper itself

Abstract

As a result of the ongoing virus-host arms race, viruses have evolved numerous immune subversion strategies, many of which are aimed at suppressing the production of type I interferons (IFNs). Apoptotic caspases have recently emerged as important regulators of type I IFN signaling both in noninfectious contexts and during viral infection. Despite being widely considered antiviral factors since they can trigger cell death, several apoptotic caspases promote viral replication by suppressing innate immune response. Indeed, we previously discovered that the AIDS-associated oncogenic gammaherpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) exploits caspase activity to suppress the antiviral type I IFN response and promote viral replication. However, the mechanism of this novel viral immune evasion strategy is poorly understood, particularly with regard to how caspases antagonize IFN signaling during KSHV infection. Here, we show that caspase activity inhibits the DNA sensor cGAS during KSHV lytic replication to block type I IFN induction. Furthermore, we used single-cell RNA sequencing to reveal that the potent antiviral state conferred by caspase inhibition is mediated by an exceptionally small percentage of IFN-β-producing cells, thus uncovering further complexity of IFN regulation during viral infection. Collectively, these results provide insight into multiple levels of cellular type I IFN regulation that viruses co-opt for immune evasion. Unraveling these mechanisms can inform targeted therapeutic strategies for viral infections and reveal cellular mechanisms of regulating interferon signaling in the context of cancer and chronic inflammatory diseases.

Indexed as

Acquired Immunodeficiency SyndromeHerpesviridae InfectionsHerpesvirus 8, HumanInterferon Type IAntiviral AgentsCaspasesHumansMembrane ProteinsNucleotidyltransferasesVirus ReplicationAntiviral AgentsCaspasesInterferon Type IMembrane ProteinsNucleotidyltransferasescaspasescGASheterogeneityinterferonsKaposi’s sarcoma-associated herpesvirus

Identifiers

PMID36255240
PMCPMC9765453
OpenAlexW4306728542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.